Macerich Co. (NYSE: MAC)’s stock price has gone decline by 0.00 in comparison to its previous close of 14.65, however, the company has experienced a 0.21% increase in its stock price over the last five trading days. businesswire.com reported 2024-08-08 that MENLO PARK, Calif.–(BUSINESS WIRE)–AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform today announced topline results from the Phase 2 part of the EBO-301 Phase 2/3 study evaluating epetraborole on top of an optimized background regimen (OBR) in treatment-refractory MAC lung disease. The Phase 2 part of the study met its primary objective of demonstrating the poten.
Is It Worth Investing in Macerich Co. (NYSE: MAC) Right Now?
The stock has a 36-month beta value of 2.54. Opinions on the stock are mixed, with 4 analysts rating it as a “buy,” 1 as “overweight,” 13 as “hold,” and 1 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for MAC is 214.14M, and at present, short sellers hold a 6.18% of that float. On August 15, 2024, the average trading volume of MAC was 1.63M shares.
MAC’s Market Performance
The stock of Macerich Co. (MAC) has seen a 0.21% increase in the past week, with a -9.06% drop in the past month, and a -11.21% fall in the past quarter. The volatility ratio for the week is 2.77%, and the volatility levels for the past 30 days are at 3.99% for MAC. The simple moving average for the last 20 days is -5.93% for MAC’s stock, with a simple moving average of -2.14% for the last 200 days.
Analysts’ Opinion of MAC
Many brokerage firms have already submitted their reports for MAC stocks, with Scotiabank repeating the rating for MAC by listing it as a “Sector Underperform.” The predicted price for MAC in the upcoming period, according to Scotiabank is $14 based on the research report published on May 17, 2024 of the current year 2024.
Piper Sandler, on the other hand, stated in their research note that they expect to see MAC reach a price target of $11, previously predicting the price at $17. The rating they have provided for MAC stocks is “Underweight” according to the report published on May 01st, 2024.
Citigroup gave a rating of “Neutral” to MAC, setting the target price at $17 in the report published on March 22nd of the current year.
MAC Trading at -3.77% from the 50-Day Moving Average
After a stumble in the market that brought MAC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -17.18% of loss for the given period.
Volatility was left at 3.99%, however, over the last 30 days, the volatility rate increased by 2.77%, as shares sank -8.44% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -4.00% lower at present.
During the last 5 trading sessions, MAC rose by +0.21%, which changed the moving average for the period of 200-days by +44.91% in comparison to the 20-day moving average, which settled at $15.51. In addition, Macerich Co. saw -5.06% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MAC starting from Volk Kenneth, who purchase 5,000 shares at the price of $15.40 back on May 10 ’24. After this action, Volk Kenneth now owns 51,924 shares of Macerich Co., valued at $77,025 using the latest closing price.
Kingsmore Scott W, the Chief Financial Officer of Macerich Co., purchase 6,000 shares at $16.06 during a trade that took place back on May 09 ’24, which means that Kingsmore Scott W is holding 42,310 shares at $96,360 based on the most recent closing price.
Stock Fundamentals for MAC
Current profitability levels for the company are sitting at:
- 0.32 for the present operating margin
- 0.31 for the gross margin
The net margin for Macerich Co. stands at -0.09. The total capital return value is set at 0.04. Equity return is now at value -2.91, with -0.97 for asset returns.
Based on Macerich Co. (MAC), the company’s capital structure generated 0.65 points at debt to capital in total, while cash flow to debt ratio is standing at 0.08. The debt to equity ratio resting at 1.82. The interest coverage ratio of the stock is 1.67.
Currently, EBITDA for the company is 459.94 million with net debt to EBITDA at 12.48. When we switch over and look at the enterprise to sales, we see a ratio of 8.6. The receivables turnover for the company is 6.2for trailing twelve months and the total asset turnover is 0.11.
Conclusion
To sum up, Macerich Co. (MAC) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
